Article thumbnail

Endovascular treatment as first line approach for infrarenal aortic occlusive disease

By Arne Gerhard Schwindt, Giuseppe Panuccio, Konstantinos P. Donas, Luca Ferretto, Martin Austermann and Giovanni Torsello

Abstract

IntroductionThe purpose of this study was to report the early and late results of primary stenting for focal atherosclerotic lesions of the infrarenal aorta.MethodsA retrospective analysis of 52 consecutive patients treated for infrarenal occlusive aortic disease with primary stenting between January 2002 and November 2009 was performed. Original angiographic imaging, medical records, and noninvasive testing were reviewed. Primary stenting was the first line of treatment. Perioperative technical success and Kaplan-Meier estimates for patency and survival were calculated.ResultsThe majority of the patients (43) were treated for severe claudication (Rutherford III; 82.7%), 5 for ischemic rest pain (Rutherford IV; 9.6%), and 4 for minor tissue loss (Rutherford V; 7.7%). Aortic stenosis was found in 40 cases (76.9%) and occlusion in 12 (23%). Perioperative hemodynamic success was 100%. All patients had an improvement of ankle brachial index (ABI) >0.10. Clinical improvement was found in 96%. Early surgical revision was necessary for aortic rupture in 1 patient. One death occurred for pneumonia. The mean follow-up time was 39.4 ± 27.2 months. Ten reinterventions (19%) were needed for symptom recurrence. The estimated assisted primary patency at 9 years was 96% and the mean survival time was 86.6 months.ConclusionPrimary stenting offers safe and durable results and should be considered as the first line of treatment for focal aortic lesions

Publisher: Society for Vascular Surgery. Published by Mosby, Inc.
Year: 2011
DOI identifier: 10.1016/j.jvs.2011.02.007
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.